Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Total Debt (2017 - 2025)

Selectis Health's Total Debt history spans 12 years, with the latest figure at $30.3 million for Q3 2025.

  • For Q3 2025, Total Debt fell 3.04% year-over-year to $30.3 million; the TTM value through Sep 2025 reached $30.3 million, down 3.04%, while the annual FY2024 figure was $30.6 million, 15.86% down from the prior year.
  • Total Debt for Q3 2025 was $30.3 million at Selectis Health, up from $12.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $38.7 million in Q3 2021 and bottomed at $2.8 million in Q3 2022.
  • The 5-year median for Total Debt is $36.0 million (2024), against an average of $29.3 million.
  • The largest annual shift saw Total Debt tumbled 92.77% in 2022 before it surged 1187.63% in 2023.
  • A 5-year view of Total Debt shows it stood at $7.1 million in 2021, then soared by 419.56% to $36.7 million in 2022, then fell by 0.95% to $36.3 million in 2023, then decreased by 15.86% to $30.6 million in 2024, then decreased by 1.0% to $30.3 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Total Debt are $30.3 million (Q3 2025), $12.0 million (Q2 2025), and $12.2 million (Q1 2025).